Brainsway
Yahoo Finance • 2 hours ago
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder
BURLINGTON, Mass. and JERUSALEM, Nov. 17, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced the launch of... Full story
Yahoo Finance • 4 days ago
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21
BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorde... Full story
Yahoo Finance • 7 days ago
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Sea Limited (SE [https://seekingalpha.com/symbol/SE]) * Workhorse Group (WKHS [https://seekingalpha.com/... Full story
Yahoo Finance • 7 days ago
BrainsWay Q3 2025 Earnings Preview
* BrainsWay (BWAY [https://seekingalpha.com/symbol/BWAY]) is scheduled to announce Q3 earnings results on Tuesday, November 11th, before market open. * The consensus EPS Estimate is $0.04 [https://seekingalpha.com/symbol/BWAY/earnings/... Full story
Yahoo Finance • 20 days ago
BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025
BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 21 days ago
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
Recent agreements withtwo additional U.S. mental health providersbring total to four in 2025 Strategy seeks to drive long-term shareholder value BURLINGTON, Mass. and JERUSALEM, Oct. 27, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ... Full story
Yahoo Finance • 3 months ago
Brainsway stock maintains Buy rating at H.C. Wainwright after strategic investments
Investing.com - H.C. Wainwright has reiterated a Buy rating and $17.00 price target on Brainsway (NASDAQ:BWAY), the $288 million market cap medical device company that has delivered an impressive 61% return year-to-date. According to Inves... Full story
Yahoo Finance • 3 months ago
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. F... Full story
Yahoo Finance • 3 months ago
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 3 months ago
BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights
Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and EBITDA guidance Rema... Full story
Yahoo Finance • 3 months ago
S&P Futures Gain as Fed Rate-Cut Bets Firm
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story
Yahoo Finance • 3 months ago
Here are the major earnings before the open Wednesday
Major earnings expected before the bell on Wednesday include: * Tencent Holdings Limited (OTCPK:TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Stratasys Ltd. (SSYS [https://seekingalpha.com/symbol/SSYS]) * Organigram Global (OGI [... Full story
Yahoo Finance • 2 years ago
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction
BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, anno... Full story
Yahoo Finance • 2 years ago
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023
BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 2 years ago
BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry
BURLINGTON, Mass. and JERUSALEM, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, tod... Full story
Yahoo Finance • 2 years ago
BrainsWay Announces Significant Expansion in Western and Central U.S.
BURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 3 years ago
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
BrainsWay BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fir... Full story
Yahoo Finance • 3 years ago
BrainsWay Launches Investigator Initiated Study (IIS) Program
BURLINGTON, Mass. and JERUSALEM, May 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today... Full story
Yahoo Finance • 3 years ago
BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression
Real-World Evidence Demonstrates the Highest Response and Remission Rates Observed to Date for Deep BURLINGTON, Mass. and JERUSALEM, March 28, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),... Full story
Yahoo Finance • 3 years ago
BrainsWay Announces Appointment of Hadar Levy as CEO
BrainsWay BURLINGTON, Mass. and JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disord... Full story
